Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSE.L Regulatory News (LSE)

  • There is currently no data for LSE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - London Stock Exchange Group Plc

17 Jan 2017 14:00

RNS Number : 3832U
FIL Limited
17 January 2017
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

FMR LLC and/or one or more of its direct or indirect subsidiaries

And

FIL Limited and/or one or more of its direct and indirect subsidiaries

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

London Stock Exchange Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16-January-17

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

If YES, specify which:

Deutsche Boerse AG

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

10,043,518

2.86%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

10,043,518

2.86%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary shares

Sale

1,600

29.41 GBP/ Share

Ordinary shares

Sale

273,400

29.42 GBP/ Share

Ordinary shares

Buy

1,600

29.41 GBP/ Share

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

17-January-17

Contact name:

Sally-Ann Hatton

Telephone number:

01737 837148

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETSFUFDWFWSEIF
Date   Source Headline
28th Jan 20213:42 pmRNSLSEG All Share Acquisition of Refinitiv - Update
19th Jan 20214:37 pmRNSExpected Completion Date
13th Jan 20211:22 pmRNSLSEG: European Commission Approval
4th Jan 20211:11 pmRNSTotal Voting Rights
14th Dec 20204:47 pmRNSDirector/PDMR Shareholding
11th Dec 20209:54 amRNSDirector/PDMR Shareholding
9th Dec 20201:03 pmRNSPublication of Prospectus and Board Appointments
1st Dec 202010:46 amRNSTotal Voting Rights
25th Nov 202010:38 amRNSDirector/PDMR Shareholding
20th Nov 202010:46 amRNSDirectorate Change
3rd Nov 20203:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202011:25 amRNSResult of Meeting
30th Oct 20203:15 pmRNSUpdate re Circular and General Meeting
23rd Oct 20207:00 amRNSTrading Statement
14th Oct 20201:02 pmRNSNotice of GM
9th Oct 20207:00 amRNSProposed Divestment of Borsa Italiana Group
1st Oct 20209:51 amRNSBlock listing Interim Review
18th Sep 20207:11 amRNSLSEG – Borsa Italiana Group Update)
14th Sep 20201:37 pmRNSDirector/PDMR Shareholding
10th Sep 20209:40 amRNSDirectorate Change
27th Aug 20209:11 amRNSDirector/PDMR Shareholding
21st Aug 20202:14 pmRNSDirector/PDMR Shareholding
3rd Aug 202012:38 pmRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSHalf-year Report
31st Jul 20207:00 amRNSLSEG All Share Acquisition of Refinitiv – Update
25th Jun 20207:00 amRNSDirectorate Change
22nd Jun 20204:54 pmRNSStatement Re EC Review of Refinitiv Transaction
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
3rd Jun 20204:08 pmRNSDirector/PDMR Shareholding
2nd Jun 20209:23 amRNSDirector/PDMR Shareholding
29th Apr 20209:43 amRNSDirector/PDMR Shareholding
22nd Apr 20203:49 pmRNSDirector/PDMR Shareholding
21st Apr 20201:05 pmRNSResult of AGM
21st Apr 202010:36 amRNSAGM Statement
21st Apr 20207:00 amRNSLSEG 2020 Q1 Trading Statement
17th Apr 20209:15 amRNSDirector/PDMR Shareholding
8th Apr 20202:16 pmRNSDirector/PDMR Shareholding
8th Apr 202010:21 amRNSLondon Stock Exchange Group plc AGM Update
1st Apr 20201:18 pmRNSBlock listing Interim Review
1st Apr 20201:13 pmRNSTotal Voting Rights
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:39 pmRNSPrice Monitoring Extension
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:03 pmRNSPrice Monitoring Extension
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202011:09 amRNSDirector/PDMR Shareholding
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.